Reneo Pharmaceuticals News

RPHMDelisted Stock  USD 18.20  1.40  8.33%   
About 55% of Reneo Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Reneo Pharmaceuticals suggests that some traders are interested regarding Reneo Pharmaceuticals' prospects. Reneo Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Reneo Pharmaceuticals. Many technical investors use Reneo Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over two months ago at globenewswire.com         
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65...
Macroaxis News: globenewswire.com
over two months ago at globenewswire.com         
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65...
Macroaxis News: globenewswire.com
over two months ago at globenewswire.com         
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
Macroaxis News: globenewswire.com
over two months ago at seekingalpha.com         
Reneo stockholders approve merger with OnKure
seekingalpha News
over two months ago at thelincolnianonline.com         
Insider Buying Reneo Pharmaceuticals, Inc. Major Shareholder Acquires 41,736.00 in Stock
news
over two months ago at investing.com         
Reneo Pharmaceuticals executive buys shares worth over 144k
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 68746 shares of Reneo Pharmaceuticals at 1.4964 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 29600 shares of Reneo Pharmaceuticals at 1.4144 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Gregory Flesher of 300000 shares of Reneo Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over three months ago at investing.com         
Reneo Pharmaceuticals executive buys over 76k in company stock
Investing News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 806 shares of Reneo Pharmaceuticals at 1.4 subject to Rule ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 55300 shares of Reneo Pharmaceuticals at 1.3582 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 172747 shares of Reneo Pharmaceuticals at 1.3712 subject to...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 150000 shares of Reneo Pharmaceuticals at 1.313 subject to ...
Macroaxis News
over three months ago at www.macroaxis.com         
Acquisition by Leonard Braden Michael of 36176 shares of Reneo Pharmaceuticals at 1.3966 subject to ...
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Reneo Pharmaceuticals that are available to investors today. That information is available publicly through Reneo media outlets and privately through word of mouth or via Reneo internal channels. However, regardless of the origin, that massive amount of Reneo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Reneo Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Reneo Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Reneo Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Reneo Pharmaceuticals alpha.

Reneo Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
RPHM Stock Earnings Reneo Pharmaceuticals Misses EPS for Q2 2024
08/13/2024
2
Acquisition by Leonard Braden Michael of 100487 shares of Reneo Pharmaceuticals at 1.4132 subject to Rule 16b-3
08/14/2024
3
RPHM Stock Alert Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders
09/03/2024
4
Acquisition by Leonard Braden Michael of 172747 shares of Reneo Pharmaceuticals at 1.3712 subject to Rule 16b-3
09/16/2024
5
Reneo Pharmaceuticals executive buys over 76k in company stock
09/19/2024
6
Acquisition by Leonard Braden Michael of 68746 shares of Reneo Pharmaceuticals at 1.4964 subject to Rule 16b-3
09/25/2024
7
Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
10/03/2024
8
OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of 65 Million
10/04/2024
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Consideration for investing in Reneo Stock

If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.